Adapting Proteostasis for Disease Intervention
Top Cited Papers
- 15 February 2008
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 319 (5865) , 916-919
- https://doi.org/10.1126/science.1141448
Abstract
The protein components of eukaryotic cells face acute and chronic challenges to their integrity. Eukaryotic protein homeostasis, or proteostasis, enables healthy cell and organismal development and aging and protects against disease. Here, we describe the proteostasis network, a set of interacting activities that maintain the health of proteome and the organism. Deficiencies in proteostasis lead to many metabolic, oncological, neurodegenerative, and cardiovascular disorders. Small-molecule or biological proteostasis regulators that manipulate the concentration, conformation, quaternary structure, and/or the location of protein(s) have the potential to ameliorate some of the most challenging diseases of our era.Keywords
This publication has 38 references indexed in Scilit:
- Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of CarcinogenesisCell, 2007
- Signal integration in the endoplasmic reticulum unfolded protein responseNature Reviews Molecular Cell Biology, 2007
- Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistanceGenes & Development, 2007
- Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation stateNature Cell Biology, 2006
- The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactionsNature Cell Biology, 2006
- Chaperonin TRiC Promotes the Assembly of polyQ Expansion Proteins into Nontoxic OligomersMolecular Cell, 2006
- Molecular Chaperones and Protein Quality ControlCell, 2006
- The Plasticity of Aging: Insights from Long-Lived MutantsCell, 2005
- Therapeutic approaches to protein-misfolding diseasesNature, 2003
- Hsp90 as a capacitor of phenotypic variationNature, 2002